SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000902664-21-001229
Filing Date
2021-02-12
Accepted
2021-02-12 08:01:52
Documents
1

Document Format Files

Seq Description Document Type Size
1 CONSTELLATION PHARMACEUTICALS, INC. p21-0328sc13ga.htm SC 13G/A 56713
  Complete submission text file 0000902664-21-001229.txt   58338
Mailing Address 215 FIRST STREET SUITE 200 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 200 CAMBRIDGE MA 02142 617-714-0555
CONSTELLATION PHARMACEUTICALS INC (Subject) CIK: 0001434418 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90572 | Film No.: 21622867
SIC: 2834 Pharmaceutical Preparations

Mailing Address 110 GREENE STREET SUITE 800 NEW YORK NY 10012
Business Address 110 GREENE STREET SUITE 800 NEW YORK NY 10012 212-937-4975
Avoro Capital Advisors LLC (Filed by) CIK: 0001633313 (see all company filings)

IRS No.: 271007403 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A